In an interview with AIS Health, ADVI’s Brenna Raines, director, policy and reimbursement, discusses the implications of an executive order, issued on October 14 by the Biden administration, directing the Centers for Medicare and Medicaid Services (CMS) Innovation Center (CMMI) to tackle drug costs. Read the full article here.